Background: Telomeres are DNA sequences on the ends of chromosomes that protect genomic integrity and shorten as cells age. Telomerase counteracts telomere shortening and prevents cellular aging. Telomerase may be inhibited by reverse transcriptase inhibitors and telomeres in T cells may be shortened by excess HIV-associated proliferation. Given association of HIV with CVD and other conditions associated with aging, we initiated systematic studies of telomere length (TL), telomerase activity (TA) and vascular function in a diverse cohort of HIV-infected and uninfected adults.
Methods: We measured TL, TA, and endothelial function in 65 HIV-infected and 24 uninfected controls. Mean PBMC TL was measured from DNA using qPCR and TA was assessed using the Gel-TRAP assay. Endothelial function was measured using flow-mediated vasodilation of the brachial artery (FMD). Generalized linear regression models with log link function were used to compare levels of TL and TA and to identify associated factors.
Results: HIV+ and control subjects had similar demographic and traditional CVD risk factors. Median TL was 0.95 in treated and virally suppressed patients and 0.93 in untreated and non-suppressed, compared with 1.07 in uninfected controls (p=0.046), while median TL was 1.02 in untreated, virally suppressed patients (p=0.72 vs. controls). TL remained 12% shorter (p=0.004) in untreated individuals with detectable viremia compared with controls after adjustment for age, gender, and race. Among HIV patients, age (10% shorter per decade, p<0.001), viral load >10K copies/mL (21% shorter vs VL<2K, p<0.001), and higher sCD163 (9% shorter per doubling, p=0.018) were independently associated with shorter TL. Correlations with FMD were weak for both TL (r=0.12, p=0.34) and TA (r=0.11, p=0.46).
Conclusions: HIV+ individuals have shorter TL compared to controls, a finding that appears to be driven by HIV replication. In particular, we found that having an HIV RNA level >10,000 copies/ml was associated with a larger reduction in TL than a decade of aging. Higher sCD163, a marker of monocyte/macrophage activation, was also independently associated with shortened TL. These data support the concept that HIV compromises telomere maintenance, perhaps with partial reversal by ART. Because TL and TA may also be influenced by monocyte/macrophage activation and other processes, larger studies are necessary to define the role of TL and telomerase in HIV+ persons.